☆ 4.7 Article

Phenazopyridine promotes RPS23RG1/Rps23rg1 transcription and ameliorates Alzheimer-associated phenotypes in mice

NEUROPSYCHOPHARMACOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Neurosciences

Recent Advances in the Modeling of Alzheimer's Disease

Hiroki Sasaguri et al.

Summary: This article introduces transgenic mouse models of Alzheimer's disease (AD) and discusses their limitations and applications. The first generation models have artificial phenotypes, while the second generation models have specific strengths and weaknesses. The third generation models exhibit more pathology and are suitable for preclinical studies. The article also provides a technical guide for using App knock-in mice in AD research and discusses the latest advances in using human tau knock-in mice and non-human primate models of AD.

FRONTIERS IN NEUROSCIENCE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation

Dongdong Zhao et al.

Summary: In this study, RPS23RG1 was found to play a role in tauopathies by regulating the degradation of p35 and suppressing Cdk5 activation to inhibit tau hyperphosphorylation. Reduced levels of RPS23RG1 trigger aberrant Cdk5-p35 activation, leading to tau hyperphosphorylation and impaired axon outgrowth. These findings suggest that RPS23RG1 may serve as a potential therapeutic target in tauopathy disorders.

CELL DEATH AND DIFFERENTIATION (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Strategies for delivering therapeutics across the blood-brain barrier

Georg C. Terstappen et al.

Summary: The blood-brain barrier presents a challenge for delivering therapeutics to the central nervous system, particularly for biopharmaceuticals. Non-invasive approaches have been developed to help overcome this challenge, with increasing research efforts focusing on technologies to deliver therapeutics to the CNS, some of which have entered clinical testing. Developing effective strategies for crossing the blood-brain barrier is crucial for treating CNS disorders, with a particular emphasis on non-invasive methods such as receptor-mediated transcytosis and the use of neurotropic viruses, nanoparticles, and exosomes.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Article Immunology

Inhibition of Smad3 in macrophages promotes Aβ efflux from the brain and thereby ameliorates Alzheimer's pathology

Lu Xu et al.

Summary: Inhibition of Smad3 signaling pathway enhances peripheral macrophage clearance of A beta, thereby alleviating AD-related pathology and cognitive deficits.

BRAIN BEHAVIOR AND IMMUNITY (2021)

添加到收藏夹

Review Neurosciences

Protective genes and pathways in Alzheimer's disease: moving towards precision interventions

Mabel Seto et al.

Summary: Alzheimer's disease is a complex neurodegenerative disorder with both genetic and environmental factors contributing to its etiology. Recent focus has shifted towards individuals who show resistance or resilience to the pathology of the disease, offering potential insights into new biological mechanisms and therapeutic targets. This review highlights some genes and variants that provide protection from AD and suggests avenues for developing precision interventions leveraging the ideas of protection and resilience.

MOLECULAR NEURODEGENERATION (2021)

添加到收藏夹

Review Neurosciences

The informed road map to prevention of Alzheimer Disease: A call to arms

Eric McDade et al.

Summary: Alzheimer's Disease prevention trials aim to intervene before significant neuronal damage occurs, with limitations including challenges in translating animal models, lack of asymptomatic disease target validation, uncertain causality in pathophysiologic changes, and limited biomarker validation for new targets. The field is advancing in developing specific biomarkers, understanding amyloid and tau pathology from asymptomatic to symptomatic stages, and creating interventions to slow or reverse amyloid pathology. Calls for more appropriate prevention animal models, biomarkers, and outcome measures for human asymptomatic prevention trials are made to accelerate AD prevention efforts.

MOLECULAR NEURODEGENERATION (2021)

添加到收藏夹

Review Neurosciences

Extracellular protein components of amyloid plaques and their roles in Alzheimer's disease pathology

M. Mahafuzur Rahman et al.

Summary: Alzheimer's disease is pathologically defined by the presence of A beta in extracellular senile plaques and tau in intracellular neurofibrillary tangles. Besides A beta, other constituents are accumulated in the plaques, mainly focusing on extracellular proteins, which may contribute to disruptions in the protein network and lead to AD and copathology. This review provides an overview of extracellular proteins interacting with A beta and their potential roles in AD pathology, as well as methods to analyze the incorporation of proteins in plaques.

MOLECULAR NEURODEGENERATION (2021)

添加到收藏夹

Review Neurosciences

Don't Phos Over Tau: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies

Yuxing Xia et al.

Summary: Phosphorylation is a common post-translational modification in tau protein isolated from Alzheimer's disease patients, with therapeutic approaches targeting phosphorylated tau showing promise in slowing hyperphosphorylation and aggregation. The identification and monitoring of phosphorylated tau could serve as disease-specific biomarkers, aiding in clinical diagnosis and progression monitoring.

MOLECULAR NEURODEGENERATION (2021)

添加到收藏夹

Review Neurosciences

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease

Tiantian Guo et al.

MOLECULAR NEURODEGENERATION (2020)

添加到收藏夹

Article Clinical Neurology

2020 Alzheimer's disease facts and figures

[Anonymous]

ALZHEIMERS & DEMENTIA (2020)

添加到收藏夹

Article Neurosciences

RPS23RG1 Is Required for Synaptic Integrity and Rescues Alzheimer's Disease-Associated Cognitive Deficits

Dongdong Zhao et al.

BIOLOGICAL PSYCHIATRY (2019)

添加到收藏夹

Review Urology & Nephrology

Macrophages: versatile players in renal inflammation and fibrosis

Patrick Ming-Kuen Tang et al.

NATURE REVIEWS NEPHROLOGY (2019)

添加到收藏夹

Article Neurosciences

A Robust and Scalable High-Throughput Compatible Assay for Screening Amyloid-β-Binding Compounds

Richard McClure et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

添加到收藏夹

Article Clinical Neurology

Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study

Bernard J. Hanseeuw et al.

JAMA NEUROLOGY (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases

Nur Izzati Mansor et al.

CURRENT DRUG DELIVERY (2019)

添加到收藏夹

Review Clinical Neurology

Alzheimer's disease: experimental models and reality

Eleanor Drummond et al.

ACTA NEUROPATHOLOGICA (2017)

添加到收藏夹

Article Multidisciplinary Sciences

RPS23RG1 reduces Aβ oligomer-induced synaptic and cognitive deficits

Li Yan et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Review Cell Biology

Phospho-specific Smad3 signaling Impact on breast oncogenesis

Elizabeth Tarasewicz et al.

CELL CYCLE (2012)

添加到收藏夹

Review Neurosciences

Amyloid Precursor Protein Processing and Alzheimer's Disease

Richard J. O'Brien et al.

ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Rps23rg gene family originated through retroposition of the ribosomal protein s23 mRNA and encodes proteins that decrease Alzheimer's β-amyloid level and tau phosphorylation

Xiumei Huang et al.

HUMAN MOLECULAR GENETICS (2010)

添加到收藏夹

Article Neurosciences

A Functional Mouse Retroposed Gene Rps23r1 Reduces Alzheimer's β-Amyloid Levels and Tau Phosphorylation

Yun-wu Zhang et al.

NEURON (2009)

添加到收藏夹

Article Biochemistry & Molecular Biology

Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology

Terrence Town et al.

NATURE MEDICINE (2008)

添加到收藏夹

Article Biochemistry & Molecular Biology

Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

Ganesh M. Shankar et al.

NATURE MEDICINE (2008)

添加到收藏夹

Article Neurosciences

Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting β-amyloid burden

Tarja M. Malm et al.

JOURNAL OF NEUROSCIENCE (2007)

添加到收藏夹

Article Medicine, Research & Experimental

Deficiency in neuronal TGF-β signaling promotes neurodegeneratbn and Alzheimer's pathology

Ina Tesseur et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

添加到收藏夹

Article Neurosciences

Altered subcellular location of phosphorylated Smads in Alzheimer's disease

Uwe Ueberham et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2006)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability

KN Dahlgren et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.